A population study of neutering status as a risk factor for canine prostate cancer
- 21 May 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (11), 1174-1181
- https://doi.org/10.1002/pros.20590
Abstract
BACKGROUND Prostate cancer has been reported to occur more commonly in neutered than intact male dogs in several case series. This study was undertaken to evaluate risk of prostate cancer in a large population database. The hypothesis was that castration is a risk factor for prostate cancer in male companion dogs. METHODS Data were derived from recorded visits to North American veterinary teaching hospitals. The Veterinary Medical Databases (VMDB) were queried to yield male dogs with urinary bladder transitional cell carcinoma (TCC), prostate adenocarcinoma (ACA), prostate TCC, prostate carcinoma (CA), and prostate tumors. A second query yielded all male dogs over the age of 4 years without a diagnosis of urinary tract cancer. These populations were compared to determine relative risks for developing each disease, singly and collectively, associated with neutering status. Odds ratios were calculated for breed as a risk factor. RESULTS Neutered males had a significantly increased risk for each form of cancer. Neutered males had an odds ratio of 3.56 (3.02–4.21) for urinary bladder TCC, 8.00 (5.60–11.42) for prostate TCC, 2.12 (1.80–2.49) for prostate adenocarcinoma, 3.86 (3.13–4.16) for prostate carcinoma, and 2.84 (2.57–3.14) for all prostate cancers. Relative risks were highly similar when cases were limited to those with a histologically confirmed diagnosis. CONCLUSIONS Breed predisposition suggests that genetic factors play a role in the development of prostate cancer. The risk associated with being neutered is highest for TCC, supporting previous work identifying the urothelium and ductular rather than acinar epithelium as the source of these tumors. Prostate 67: 1174–1181, 2007.Keywords
This publication has 33 references indexed in Scilit:
- Nuclear Imaging of Met-Expressing Human and Canine Cancer Xenografts with Radiolabeled Monoclonal Antibodies (MetSeekTM)Clinical Cancer Research, 2005
- Canine Prostate Carcinomas Express Markers of Urothelial and Prostatic DifferentiationVeterinary Pathology, 2004
- Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapyJournal of Cellular Biochemistry, 2004
- Canine prostatic intraepithelial neoplasia: Is the comparative model relevant?The Prostate, 2003
- Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration timeVeterinary and Comparative Oncology, 2003
- Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 casesThe Prostate, 2000
- High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancerThe Prostate, 1998
- Prostatic Intraepithelial Neoplasia Occurs Spontaneously in the Canine ProstateJournal of Urology, 1997
- Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancerThe Prostate, 1997
- Fifteen cases of prostatic carcinoma in the dogPublished by Wiley ,1981